Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis A substudy of the ABSORB clinical trial
Authors:
- Nieves GonzaloNGNieves Gonzalo
- Ravindra PawarRPRavindra Pawar
- Neville KukrejaNKNeville Kukreja
- Dariusz DudekDDDariusz Dudek
- Leif ThuesenLTLeif Thuesen
- John OrmistonJOJohn Ormiston
- Evelyn RegarEREvelyn Regar
- Patrick SerruysPSPatrick Serruys
- 1 January 2009
- journal article
- clinical trial
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 4 (4) , 443-448
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 16 references indexed in Scilit:
- A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialThe Lancet, 2008
- Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsNew England Journal of Medicine, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Coronary-Artery StentsNew England Journal of Medicine, 2006
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004